Simplicity Wealth LLC Acquires New Shares in Astera Labs, Inc. $ALAB

Simplicity Wealth LLC acquired a new position in Astera Labs, Inc. (NASDAQ:ALABFree Report) in the second quarter, HoldingsChannel reports. The fund acquired 1,797 shares of the company’s stock, valued at approximately $868,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ALAB. Reflection Asset Management bought a new stake in shares of Astera Labs in the 4th quarter valued at about $25,000. Smartleaf Asset Management LLC boosted its stake in shares of Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in shares of Astera Labs during the fourth quarter valued at approximately $33,000. Whipplewood Advisors LLC boosted its stake in shares of Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after purchasing an additional 319 shares in the last quarter. Finally, Assetmark Inc. increased its holdings in Astera Labs by 78.9% during the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after buying an additional 101 shares during the period. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Price Performance

NASDAQ ALAB opened at $321.61 on Monday. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The company has a 50 day moving average price of $358.00 and a 200 day moving average price of $240.74. The firm has a market cap of $55.80 billion, a PE ratio of 159.21 and a beta of 3.84.

Astera Labs (NASDAQ:ALABGet Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same period last year, the firm earned $0.44 earnings per share. Astera Labs’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities research analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently commented on ALAB shares. Citigroup reissued a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. Susquehanna lifted their price target on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a report on Friday, July 31st. Jefferies Financial Group lifted their price target on Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Bank of America boosted their price target on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 23rd. Finally, Stifel Nicolaus upped their price objective on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $325.25.

Get Our Latest Analysis on ALAB

Insiders Place Their Bets

In other news, Director Stefan A. Dyckerhoff sold 3,505 shares of the stock in a transaction on Thursday, August 6th. The stock was sold at an average price of $311.83, for a total transaction of $1,092,964.15. Following the completion of the sale, the director owned 53,961 shares in the company, valued at approximately $16,826,658.63. This represents a 6.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 686 shares of the firm’s stock in a transaction on Wednesday, June 24th. The stock was sold at an average price of $395.04, for a total value of $270,997.44. Following the completion of the sale, the director directly owned 5,550 shares of the company’s stock, valued at $2,192,472. The trade was a 11.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 940,716 shares of company stock worth $292,425,777. 10.40% of the stock is currently owned by company insiders.

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Further Reading

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.